1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | During interviews with the clients, none of them corroborated the allegation. C1 stated that they have not had any issues in obtaining their medications from staff. Another client interviewed stated that they are obtaining all the medications that they require. During interviews with the staff, three (3) out of four (4) staff corroborated the allegation. One staff interviewed stated that they recognized that C1 was not administered their Olanzapine and Vitamin D3 medications in the morning on 2/4/2026, and subsequently conducted an in-service training among staff on medication administration. Another staff interviewed that they likewise participated in the in-service training on medication administration following the medication error. Based on review of C1's MARs for the month of February, the initial is circled to indicate that the medication was not administered. The findings on the CAP from ELARC similarly describes that the medications were missed and that C1's primary care provider and psychiatrist was notified, and C1 did not have any adverse reactions to the missed medications. An SIR reviewed dated 2/9/2026 also describes that C1's medications for Olanzapine and Vitamin D3 were missed on 2/4/2026. During medication review for C1 - C4 at the time of the visit, LPA did not observe any additional medication errors since the one on 2/4/2026.
Based on LPA interviews conducted with the clients and staff, the preponderance of evidence standard has been met for the above allegations, therefore the allegation is found to be SUBSTANTIATED. California Code of Regulations Title 22, Division 6, Chapter 1 is being cited on the attached LIC9099D page.
Exit interview was held and a copy of the report along with the appeal rights were provided and will be emailed to the administrator. |